To validate the functional role of MICA ∗012:01 in CRC malignancy, we analyzed the disease-free survival time (DFS) of patients with CRC that carry the KRAS codon 12 mutation and contain MICA ∗012:01 to those that do not have MICA ∗012:01. The gene discussed is KRAS; the disease is colorectal carcinoma.